Occult HBV infection
Open Access
- 26 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Seminars in Immunopathology
- Vol. 35 (1), 39-52
- https://doi.org/10.1007/s00281-012-0327-7
Abstract
The long-lasting persistence of hepatitis B virus (HBV) genomes in the liver (with detectable or undetectable HBV DNA in the serum) of individuals testing negative for the HBV surface antigen (HBsAg) is termed occult HBV infection (OBI). Although in a minority of cases the lack of HBsAg detection is due to infection with variant viruses unrecognized by available assays (S-escape mutants), the typical OBI is related to replication-competent HBVs strongly suppressed in their replication activity. The causes of HBV suppression are not yet well clarified, although the host’s immune surveillance and epigenetic mechanisms are likely involved. OBI is a worldwide diffused entity, but the available data of prevalence in various categories of individuals are often contrasting because of the different sensitivity and specificity of the methods used for its detection in many studies. OBI may have an impact in several different clinical contexts. In fact, it can be transmitted (i.e., through blood transfusion and liver transplantation) causing classic forms of hepatitis B in newly infected individuals. The development of an immunosuppressive status (mainly by immunotherapy or chemotherapy) may induce OBI reactivation and development of acute and often severe hepatitis. Finally, evidence suggests that OBI can favor the progression of liver fibrosis, in particular in HCV-infected patients. The possible contribution of OBI to the establishment of cirrhosis also implies its possible indirect role in the development of hepatocellular carcinoma. On the other hand, OBI may maintain most of the direct transforming properties of the overt HBV infection, such as the capacity to integrate in the host’s genome and to synthesize pro-oncogenic proteins.This publication has 103 references indexed in Scilit:
- Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virusJournal of Viral Hepatitis, 2010
- Epigenetic regulation of latent HSV-1 gene expressionBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTBone Marrow Transplantation, 2010
- Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA functionProceedings of the National Academy of Sciences of the United States of America, 2009
- Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individualsCytokine, 2009
- Methylation Regulates Hepatitis B Viral Protein ExpressionThe Journal of Infectious Diseases, 2009
- The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus InfectionGastroenterology, 2008
- Comprehensive Genetic and Epigenetic Analysis of Occult Hepatitis B from Liver Tissue SamplesClinical Infectious Diseases, 2008
- Chromatin organization and virus gene expressionJournal of Cellular Physiology, 2008
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyGastroenterology, 2004